Multidrug‐resistant OXA‐48‐producing Klebsiella pneumoniae mediastinitis treated safely and effectively with imipenem and colistin

References

1. Biswas S., Brunel J.M., Dubus J.C., Reynaud‐Gaubert M., Rolain J.M. ( 2012). Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 10:917–934 [CrossRef]
   [Google Scholar]
2. CLSI( 2009). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically 8th edn. Approved standard M07‐A8 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
3. Daikos G.L., Markogiannakis A. ( 2011). Carbapenemase‐producing Klebsiella pneumoniae: (when) might we still consider treating carbapenem?. Clin Microbiol Infect 8:1135–1141 [CrossRef]
   [Google Scholar]
4. Nordmann P., Naas T., Poirel L. ( 2011). Global spread of carbapenemase‐producing Enterobacteriaceae . Emerg Infect Dis 17:1791–1798 [CrossRef]
   [Google Scholar]
5. Risnes I., Abdelnoor M., Almdahl S.M., Svenneving J.L. ( 2010). Mediastinitis after coronary artery bypass grafting risk factors and long‐term survival. Ann Thorac Surg 89:1502–1509 [CrossRef]
   [Google Scholar]